United StatesPresident Donald Trump signed an executive order in April 2026 to expedite the FDA's review of psychedelic drugs like ibogaine, psilocybin, and MDMA for treating mental health conditions, particularly among veterans. The move was influenced by advocacy from figures like Joe Rogan and military veterans who credit psychedelics with helping them recover from trauma and addiction. The order includes funding for state programs and collaboration with the Department of Veterans Affairs. Former Navy SEAL Marcus Luttrell praised the initiative, stating it could 'save a lot of lives.' The FDA has since approved initial trials for ibogaine and issued national priority vouchers for psilocybin and methylone. The decision reflects growing interest in psychedelic therapy for mental health treatment.
Bias read (Center): While the article discusses a politically sensitive topic—government regulation of psychedelic drugs—the framing appears balanced. It presents both the advocacy from supporters like Joe Rogan and veterans, as well as the administrative action taken by the Trump administration. There is no overtly sl
